Danimer Scientific, Inc. (DNMR)

Danimer Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	73.5	64.4	286.97	379.9	9.28
Cash & Cash Equivalents	73.5	64.4	286.97	379.9	9.28
Cash Growth	14.13%	-77.56%	-24.46%	3994.60%	41.74%
Receivables	15.88	19.62	20.99	6.61	4.77
Inventory	25.27	32.74	24.57	13.64	7.04
Other Current Assets	-6.62	8.3	7.83	2.24	-1.84
Total Current Assets	108.04	125.07	340.36	402.38	19.24
Property, Plant & Equipment	464.31	472.98	335.42	126.18	92.41
Long-Term Investments	31.45	31.45	13.41	13.41	27.74
Goodwill and Intangibles	77.79	80.94	147.31	1.8	2.05
Other Long-Term Assets	16.54	1.84	2.1	2.43	3.13
Total Long-Term Assets	590.09	587.2	498.24	143.82	125.33
Total Assets	698.13	712.27	838.6	546.2	144.57
Accounts Payable	5.29	14.98	20.79	10.61	8.12
Deferred Revenue	1	0	0.21	2.46	4.58
Current Debt	4.71	5.31	3.69	28.2	11.86
Other Current Liabilities	4.73	5	18.78	9.22	9.72
Total Current Liabilities	15.72	25.29	43.48	50.49	34.28
Long-Term Debt	403.36	308.51	283.63	55.56	91.21
Other Long-Term Liabilities	1.03	0.86	11.23	84.11	2.5
Total Long-Term Liabilities	404.39	309.37	294.86	139.67	93.71
Total Liabilities	420.11	334.66	338.33	190.16	128
Total Debt	408.07	313.82	287.32	83.76	103.07
Debt Growth	30.03%	9.22%	243.02%	-18.74%	34.80%
Retained Earnings	-454.12	-298.65	-118.89	-58.78	-49.93
Shareholders' Equity	278.02	377.61	500.27	356.04	16.58
Net Cash / Debt	-334.56	-249.42	-0.35	296.14	-93.8
Net Cash Per Share	-3.28	-2.47	-0.00	10.01	-3.70
Working Capital	92.32	99.78	296.88	351.9	-15.05
Book Value Per Share	2.73	3.73	5.38	12.04	0.65

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).